Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm Metastasis 1Lymphoma, Large B-Cell, Diffuse 1Leukemia 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1Breast Neoplasms 1

Interventions

fludarabine phosphate 2fludarabine 2Specimen Handling 2Melphalan 2Cyclophosphamide 2vactosertib 1azathiopurine 1aldesleukin 1Tacrolimus 1Stem Cell Transplantation 1Radiotherapy, Intensity-Modulated 1RFB4(dsFv)-PE38 recombinant immunotoxin 1Prednisolone 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methylprednisolone 1Mercaptopurine 1Magnetic Resonance Spectroscopy 1Leukapheresis 1Interleukin-2 1Imatinib Mesylate 1IL32 protein, human 1Health Promotion 1Educational Status 1Cytarabine 1Cetuximab 1Biopsy 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Antibodies, Monoclonal × Clear all
NCT00077493 2007-12-28

BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

MedImmune LLC

Phase 1 Suspended
95 enrolled
LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Leukemia, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡